RecruitingPhase 1NCT02781519
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans
Sponsor
Yale University
Enrollment
100 participants
Start Date
Jun 1, 2015
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.
Eligibility
Min Age: 18 YearsMax Age: 55 Years
Inclusion Criteria2
- at least one lifetime exposure to cannabis
- good physical and mental health
Exclusion Criteria3
- cannabis naive individuals
- major current or recent stressors
- taking estrogen supplements or oral contraceptive pills (for women)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGTHC
Active THC (0.015mg/kg) administered over 10 minutes
DRUGPlacebo
Control: small amount of alcohol (quarter teaspoon), with no THC over 10 minutes
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02781519
Related Trials
Repeated CBD Administration and Cannabis Outcomes
NCT074348951 location
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
NCT0562970222 locations
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
NCT055148991 location
Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study II
NCT047042711 location
Reducing Breathlessness With Dronabinol in COPD Patients
NCT064737011 location